MBOT News and Press, Microbot Medical Inc. From 12/27/21

Gainers: Microbot Medical (NASDAQ:MBOT) +51%, CollPlant Biotechnologies (NASDAQ:CLGN) +27%, Lucira Health (NASDAQ:LHDX) +14%, IceCure Medical (NASDAQ:ICCM) +13%, Cue Health (NASDAQ:HLTH) +12%. Losers: BridgeBio Pharma (NASDAQ:BBIO) -71%, Biond...

Microbot Medical (NASDAQ:MBOT) soars 46.7% premarket after entering into a strategic collaboration agreement with Stryker (NYSE:SYK), a global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instrum...

HINGHAM, Mass., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker’s Neurovascular division ...

Microbot Medical (NASDAQ:MBOT) announces that the USPTO has issued a Notice of Allowance for a third patent application covering the Company’s LIBERTY Robotic System. Shares up 8.7% premarket at $5.50. The allowed claims provide protection for embodiments of LIBERTY as a...

HINGHAM, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a third patent application covering the Company’s LIBERTY ® Robotic System. The C...

HINGHAM, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has and will continue to implement key initiatives that will prepare the LIBERTY® Robotic System for commercialization. In conjunction with recently announced design freeze, Dr. Eya...

HINGHAM, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) achieved the design freeze objective for the LIBERTY® Robotic System. This milestone demonstrates the continued progress towards the commercialization of the world’s first fully disposable rob...

The USPTO has issued a notice of allowance for Microbot Medical's (NASDAQ:MBOT) second patent application covering the company’s LIBERTY Robotic System. The allowed claims cover a modular robotic system for manipulation of at least two elongated, flexible surgical tools, the syste...

HINGHAM, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trade Office (USPTO) has issued a Notice of Allowance for a second patent application covering the Company’s LIBERTY ® Robotic System. Globally...

Voyager Therapeutics (NASDAQ:VYGR) +44% Pfizer in pact with Voyager Therapeutics to develop gene therapies Acer Therapeutics (NASDAQ:ACER) +14%. Kaixin Auto (NASDAQ:KXIN) +8% as POCCO EV orders surpassed 3000 units in September, +130% M/M Palantir Technologies (NYSE:PLTR)&...